Background: Since transient ischemic attacks (TIAs) can predict future stroke, it is important to distinguish true vascular events from non-vascular etiologies. Arterial spin labeling (ASL) is a non-contrast magnetic resonance (MR) method that is sensitive to cerebral perfusion and arterial arrival delays. Due to its high sensitivity to minor perfusion alterations, we hypothesized that ASL abnormalities would be identified frequently in TIA patients, and could therefore help increase clinicians’ confidence in the diagnosis. Methods: We acquired diffusion-weighted imaging (DWI), intracranial MR angiography (MRA), and ASL in a prospective cohort of TIA patients. A subset of these patients also received bolus contrast perfusion-weighted imaging (PWI). Two neuroradiologists evaluated the images in a blinded fashion to determine the frequency of abnormalities on each imaging sequence. Kappa (ĸ) statistics were used to assess agreement, and the χ2 test was used to detect differences in the proportions of abnormal studies. Results: 76 patients met the inclusion criteria, 48 (63%) of whom received PWI. ASL was abnormal in 62%, a much higher frequency compared with DWI (24%) and intracranial MRA (13%). ASL significantly increased the MR imaging yield above the combined DWI and MRA yield (62 vs. 32%, p < 0.05). Arterial transit artifact in vascular borderzones was the most common ASL abnormality (present in 51%); other abnormalities included focal high or low ASL signal (11%). PWI was abnormal in 31% of patients, and in these, ASL was abnormal in 14 out of 15 cases (93%). In hemispheric TIA patients, both PWI and ASL findings were more common in the symptomatic hemisphere. Agreement between neuroradiologists regarding abnormal studies was good for ASL and PWI [ĸ = 0.69 (95% CI 0.53–0.86) and ĸ = 0.66 (95% CI 0.43–0.89), respectively]. Conclusion: In TIA patients, perfusion-related alterations on ASL were more frequently detected compared with PWI or intracranial MRA and were most frequently associated with the symptomatic hemisphere. Almost all cases with a PWI lesion also had an ASL lesion. These results suggest that ASL may aid in the workup and triage of TIA patients, particularly those who cannot undergo a contrast study.

1.
Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901–2906.
2.
Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S: Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007;369:283–292.
3.
Castle J, Mlynash M, Lee K, Caulfield AF, Wolford C, Kemp S, Hamilton S, Albers GW, Olivot JM: Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. Stroke 2010;41:1367–1370.
4.
Amort M, Fluri F, Schafer J, Weisskopf F, Katan M, Burow A, Bucher HC, Bonati LH, Lyrer PA, Engelter ST: Transient ischemic attack versus transient ischemic attack mimics: frequency, clinical characteristics and outcome. Cerebrovasc Dis 2011;32:57–64.
5.
Ay H, Arsava EM, Johnston SC, Vangel M, Schwamm LH, Furie KL, Koroshetz WJ, Sorensen AG: Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. Stroke 2009;40:181–186.
6.
Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan AM, Demchuk AM: An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke 2008;3:3–10.
7.
Calvet D, Touze E, Oppenheim C, Turc G, Meder JF, Mas JL: DWI lesions and TIA etiology improve the prediction of stroke after TIA. Stroke 2009;40:187–192.
8.
Giles MF, Albers GW, Amarenco P, Arsava MM, Asimos A, Ay H, Calvet D, Coutts S, Cucchiara BL, Demchuk AM, Johnston SC, Kelly PJ, Kim AS, Labreuche J, Lavallee PC, Mas JL, Merwick A, Olivot JM, Purroy F, Rosamond WD, Sciolla R, Rothwell PM: Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4,574 patients. Stroke 2010;41:1907–1913.
9.
Perez A, Restrepo L, Kleinman JT, Barker P, Beauchamp N, Wityk RJ: Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 h or more after stroke symptom onset: clinical and imaging features. J Neuroimaging 2006;16:329–333.
10.
Restrepo L, Jacobs MA, Barker PB, Wityk RJ: Assessment of transient ischemic attack with diffusion- and perfusion-weighted imaging. AJNR Am J Neuroradiol 2004;25:1645–1652.
11.
Krol AL, Coutts SB, Simon JE, Hill MD, Sohn CH, Demchuk AM: Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke 2005;36:2487–2489.
12.
Mlynash M, Olivot JM, Tong DC, Lansberg MG, Eyngorn I, Kemp S, Moseley ME, Albers GW: Yield of combined perfusion and diffusion MR imaging in hemispheric TIA. Neurology 2009;72:1127–1133.
13.
Prabhakaran S, Patel SK, Samuels J, McClenathan B, Mohammad Y, Lee VH: Perfusion computed tomography in transient ischemic attack. Arch Neurol 2011;68:85–89.
14.
Tong T, Yao Z, Feng X: Combined diffusion- and perfusion-weighted imaging: a new way for the assessment of hemispheric transient ischemic attack patients. Int J Dev Neurosci 2011;29:63–69.
15.
Roberts DA, Detre JA, Bolinger L, Insko EK, Leigh JS: Quantitative magnetic resonance imaging of human brain perfusion at 1.5 T using steady-state inversion of arterial water. Proc Natl Acad Sci 1994;91:33–37.
16.
Detre JA, Samuels OB, Alsop DC, Gonzalez-At JB, Kasner SE, Raps EC: Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging 1999;10:870–875.
17.
Zaharchuk G, Bammer R, Straka M, Shankaranarayan A, Alsop DC, Fischbein NJ, Atlas SW, Moseley ME: Arterial spin-label imaging in patients with normal bolus perfusion-weighted MR imaging findings: pilot identification of the borderzone sign. Radiology 2009;252:797–807.
18.
Macintosh BJ, Lindsay AC, Kylintireas I, Kuker W, Guther M, Robson MD, Kennedy J, Choudhury RP, Jezzard P: Multiple inflow pulsed arterial spin-labeling reveals delays in the arterial arrival time in minor stroke and transient ischemic attack. AJNR Am J Neuroradiol 2010;31:1892–1894.
19.
Dai W, Garcia D, de Bazelaire C, Alsop DC: Continuous flow driven inversion for arterial spin labeling using pulsed radiofrequency and gradient fields. Magn Reson Med 2008;60:1488–1497.
20.
Newbould RD, Skare ST, Jochimsen TH, Alley MT, Moseley ME, Albers GW, Bammer R: Perfusion mapping with multiecho multishot parallel imaging EPI. Magn Reson Med 2007;58:70–81.
21.
Straka M, Albers GW, Bammer R: Real-time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010;32:1024–1037.
22.
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174.
23.
Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuk AM: Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 2005;57:848–854.
24.
Bisschops RH, Kappelle LJ, Mali WP, van der Grond J: Hemodynamic and metabolic changes in transient ischemic attack patients: a magnetic resonance angiography and (1)H-magnetic resonance spectroscopy study performed within 3 days of onset of a transient ischemic attack. Stroke 2002;33:110–115.
25.
Heiss WD, Zaro Weber O: Uncertainties in the assessment of cortical flow by perfusion-weighted MRI in acute stroke. Cerebrovasc Dis 2011;32:194–195; author reply 196.
26.
Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–517.
27.
Zaharchuk G, Straka M, Marks MP, Albers GW, Moseley ME, Bammer R: Combined arterial spin label and dynamic susceptibility contrast measurement of cerebral blood flow. Magn Reson Med 2010;63:1548–1556.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.